The Australian Therapeutic Trial in Mild Hypertension

Nephron
A E Doyle

Abstract

In the Australian Therapeutic Trial in Mild Hypertension treated patients had significantly lower cardiovascular mortality and a significantly lower incidence of cerebrovascular complications than patients given placebos. There was, however, no difference in the incidence of nonfatal myocardial infarction or other new manifestations of ischaemic heart disease. Although the evidence of benefit from treatment was clear-cut, the number of cardiovascular complications in the control group was small. This was due to several factors. Patients admitted to the trial had no preceding evidence of cardiovascular complications, the blood pressure fell spontaneously to below 95 mm Hg in almost half the control group, and patients whose blood pressures rose to levels above 110 mm Hg were given treatment, but remained in the placebo group for analysis. In both treated and placebo groups, trial end-points occurred more frequently in persons whose average diastolic blood pressure during the study remained raised. Ischaemic heart disease and many cases of stroke are due to atherosclerotic arterial disease. This appears not to be favourably influenced by antihypertensive drug therapy.

Citations

Apr 6, 2012·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·I van DisD Kromhout
Jan 13, 2000·Journal of General Internal Medicine·A QuanJ P Boissel
Nov 1, 1987·Journal of General Internal Medicine·W Engel, J Sawyer
May 11, 2002·Current Hypertension Reports·Ehud GrossmanUri Goldbourt
Jun 18, 2011·Current Hypertension Reports·Debbie L Cohen, Raymond R Townsend
Sep 4, 2012·Current Cardiology Reports·Louis Kuritzky
Sep 30, 1998·Journal of Psychosomatic Research·S J Mann, G D James
Oct 1, 1991·Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society·R H Rosenman
May 20, 1998·British Journal of Urology·L Hansson
Dec 1, 1992·Cardiovascular Drugs and Therapy·M Moser
Dec 1, 1991·Cardiovascular Drugs and Therapy·J R Hampton
Jul 1, 1987·Diabetes/metabolism Reviews·M F Lopes-Virella, J A Colwell
Apr 19, 2018·The Cochrane Database of Systematic Reviews·James M WrightRupam Gill
Jul 10, 2009·The Cochrane Database of Systematic Reviews·James M Wright, Vijaya M Musini
Jun 6, 2019·The Cochrane Database of Systematic Reviews·Vijaya M MusiniJames M Wright
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Diana DiaoFrancois Gueyffier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.